Omalizumab and dupilumab for the treatment of autosomal-recessive DOCK8 hyper-IgE syndrome.

Guo, Ting; Wei, Lili; Karki, Saroj; Wen, Sijian; Li, Qiuju; Lin, Youkun

Guo, Ting; Wei, Lili; Karki, Saroj; Wen, Sijian; Li, Qiuju; Lin, Youkun.

Afiliación

Guo T; Department of Dermatology and Venereology, The first affiliated Hospital of Guangxi Medical University, Guangxi, China.
Wei L; Department of Dermatology and Venereology, The first affiliated Hospital of Guangxi Medical University, Guangxi, China.
Karki S; Department of Dermatology and Venereology, The first affiliated Hospital of Guangxi Medical University, Guangxi, China.
Wen S; Department of Dermatology and Venereology, The first affiliated Hospital of Guangxi Medical University, Guangxi, China.
Li Q; Department of Dermatology and Venereology, The first affiliated Hospital of Guangxi Medical University, Guangxi, China.
Lin Y; Department of Dermatology and Venereology, The first affiliated Hospital of Guangxi Medical University, Guangxi, China.

Indian J Dermatol Venereol Leprol ; : 1-3, 2023 Oct 17.

Article en En | MEDLINE | ID: mdl-38031685

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Indian J Dermatol Venereol Leprol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google